本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Cullinan Therapeutics

22.95
+1.135.18%
盤後23.340.3889+1.69%19:30 EDT
成交量:51.93萬
成交額:1,185.67萬
市值:14.77億
市盈率:-6.62
高:23.06
開:22.16
低:22.16
收:21.82
52周最高:23.06
52周最低:5.68
股本:6,435.47萬
流通股本:4,808.28萬
量比:0.73
換手率:1.08%
股息:- -
股息率:- -
每股收益(TTM):-3.4680
每股收益(LYR):-3.7236
淨資產收益率:-50.30%
總資產收益率:-31.36%
市淨率:4.59
市盈率(LYR):-6.16

資料載入中...

2026/08/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

重要事件披露

Form 8-K - Current report
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/06

重要事件披露

Form 8-K - Current report
2026/07/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/16

重要事件披露

Form 8-K - Current report
2026/06/10

重要事件披露

Form 8-K - Current report
2026/06/08

重要事件披露

Form 8-K - Current report
2026/05/18

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/10

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/10

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/10

重要事件披露

Form 8-K - Current report
2026/03/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities